Variation in blood levels of hormones in XXXX @entity1 following @entity353 induced by endoscopic and surgical bariatric therapies.

@entity1 @entity353 @entity28 @entity1243 @entity37462 @entity26156 @entity1254
BACKGROUND: Beneficial clinical effects of @entity353 following bariatric therapies is not fully understood and maybe related to the complex interactions between @entity1243 , @entity1254 , @entity26156 , @entity37462 , and ghrelin. The aim of study was to investigate their timeline changes associated with @entity353 and their profile in relation to the type of treatment and its efficacy. METHODS: Circulating hormones levels were analyzed before and after endoscopic and surgical procedures in 67 @entity28 @entity1 and compared to @entity28 healthy controls. RESULTS: @entity28 @entity1 had higher @entity1243 levels and lower levels of @entity1254 , @entity26156 , @entity37462 , and ghrelin than @entity28 controls. During the consecutive follow-up visits after treatment, there was a gradual decrease in @entity1243 levels and an increase in @entity1254 levels to the levels observed in @entity28 . At 50-54weeks, the ghrelin levels were lower and the levels of @entity1254 and @entity26156 , but not @entity37462 , were higher compared to their baseline values. BMI correlated with ghrelin and @entity1243 levels. The percentage of total @entity353 correlated positively with @entity1254 levels and negatively with @entity1243 levels. @entity1 with adequate @entity353 had a significantly lower @entity1243 concentration than those with treatment failure. There were timeline variations in hormone levels between endoscopic and bariatric therapies, however there were no significant differences in the median their concentration at 50-54weeks after therapy. CONCLUSION: Our study supports observations that @entity353 itself, rather than the procedure type, is responsible for hormonal variation. The @entity1243 levels reflect the best the body weight changes after bariatric therapies.
